Introduction
Rheumatoid factors (RF)' have classically been defined as antiIgG immunoglobulins that react with autologous and heterologous IgG. They are detected in -70% of patients with rheumatoid arthritis (RA), 30% of patients with systemic lupus erythematosus (SLE), as well as in patients with other connective tissue diseases (1) . In addition, RF can be found in patients with chronic inflammatory diseases, such as leprosy, tuberculosis, syphilis, subacute endocarditis, and salmonellosis, and in other conditions associated with hypergammaglobulinemia or circulating immune complexes (1) . The origin and function of antiimmunoglobulin antibodies (RF) in each of these diseases is 1 . Abbreviations used in this paper: dDNA, denatured DNA; HIgG, human IgG; nDNA, native DNA; PBL, peripheral blood lymphocytes; PBS, phosphate-buffered saline, pH 7.3; PTT, partial thromboplastin time; RA, rheumatoid arthritis; RF, rheumatoid factor(s); RIA, radioimmunoassay(s); SLE, systemic lupus erythematosus.
unknown. However, studies on monoclonal and polyclonal RF isolated from serum have shown that RF can react with a variety of substances other than IgG, including nitrophenyl groups and denatured DNA (dDNA) (2) , nucleosomes (3, 4) , DNA-nucleoprotein complexes (5), histones (6) (7) (8) , nonhistone nuclear proteins (9) , and bromelin-treated erythrocytes (10) . The assays on both the hybridoma antibody applied to the immunoabsorbents and the effluent fractions from the columns. In both the case of the Sepharose-HIgG and the control Sepharose-BSA column, 100% of PTT activity was recovered in the effluent after the absorption experiment. As the PTT assay used was extremely sensitive, complete recovery of this antibody activity indicated that the immunoabsorbents did not remove antibodies in a nonspecific manner. Competition ofbinding ofhybridoma RF to Fc-coated tubes by HIgG, dDNA, and BSA. Fig. 1 demonstrates the cross-reactivity of the hybridoma antibodies, which are both RF and anti-DNA antibodies. As seen in Fig. 1 , the binding ofthese antibodies to Fc-coated tubes was competed by HIgG and dDNA, but not by BSA. In the case of antibody SLE 1400 (Fig. 1 A) , a strong RF-reactive antibody, HIgG was a better competitor than DNA by a factor of -10. The binding of antibody RA 1859 (Fig. 1  B) to Fc tubes, on the other hand, was competed better by dDNA than by HIgG. 50% inhibition of binding was achieved at 0.02 ;zg/ml of dDNA and 0. 14 ,gg/ml of HIgG, while no competition was observed at 15 jig/ml of BSA. Competition of the binding of RA hybridoma antibody 18141 to Fc-coated tubes by dDNA, HIgG, and BSA. In direct binding assays, this hybridoma antibody reacted with HIgG and Fc, but showed no reactivity to dDNA. In Fig. 2 , the RF activity of RA hybridoma antibody 18141 was inhibited by HIgG but not by dDNA.
by HIgG, with 50% inhibition attained at 0.26 iig/ml HIgG, while no competition was achieved with up to 4 Ag/ml dDNA.
Isoelectricfocusing. Fig. 3 shows a representative isoelectric focusing gel ofthe isolated light chains from six hybridoma anti-DNA antibodies, of which four (1836, 2607, 1400, and 1401) had specific reactivity with both dDNA and Fc by direct binding RIA, competitive assays on dDNA and Fc, and immunoabsorption on Sepharose-HIgG columns. Each hybridoma antibody produced a pattern of 1-3 major bands, characteristic of the bands seen with isoelectric focusing gels of myeloma (22) and mouse monoclonal hybridoma (Gibson, D., personal communication) light chains. Interestingly, five of the six antibodies had two identical bands, suggesting a preferred light chain in these autoantibodies. The presence of 2-3 bands with heterogeneous charge properties is believed to be due to postsynthetic deamidation, or loss of labile amide groups from the immu- noglobulin molecules. This can result in mobility shifts of a single-or double-band spacing (22) .
Of the 17 clones listed in Table I , only 10 were examined by isoelectric focusing, and 9 were monoclonal. The one antibody (18141) that did not appear to be monoclonal was not reactive with both DNA and Fc, but reacted solely as a RF. The remaining seven clones were lost to contamination, and frozen aliquots of cells, when thawed, were no longer viable, leaving us unable to perform isoelectric focusing on the antibodies produced by these clones. Thus, all eight clones that manifested strong dual reactivity as RF and anti-DNA autoantibodies were analyzed by isoelectric focusing and all were monoclonal.
Discussion
This study demonstrates that a single human hybridoma autoantibody can have both anti-DNA and RF reactivities. Of262 hybridomas obtained from RA and SLE patients, 17 hybridomas were found to produce antibodies that reacted with either dDNA, the Fc fragment of human IgG, or both. 6% (1/17) reacted with Fc only, 29% (5/17) with dDNA only, and 65% with both Fc and dDNA. The study focuses, in particular, on the eight hybridoma antibodies with the strongest reactivities with both dDNA and Fc, and demonstrates, by direct binding, inhibition studies, immunoabsorbent experiments, and isoelectric focusing gels, that both antibody activities are due to a single hybridoma antibody.
Antibodies with both RF reactivity and high dDNA-binding activity were applied to Sepharose-HIgG and Sepharose-BSA immunoabsorbent columns. The Sepharose-HIgG immunoabsorbent removed 100% of the RF and 91.5% of the anti-DNA activities for RA hybridoma 1836, and 60% of the RF and 91% of the anti-DNA activities of SLE hybridoma 1400. A second absorption of SLE hybridoma antibody 1400 on the SepharoseHIgG column (results not shown) removed the remaining 40% RF and 9% anti-DNA activities present after the first SepharoseIgG absorption. In both the case of 1836 and 1400, elution from the Sepharose-HIgG column resulted in complete recovery of the RF activity, but only 10% recovery ofthe anti-DNA activity. Similar losses (>80%) ofanti-dDNA activity have been reported by Lafer et al. (23) for serum absorptions on a dDNA immunoabsorbent column. In the present study, the 10% anti-dDNA activity was shown to be specifically bound to the SepharoseHIgG, as the anti-DNA activity eluted from the control Sepharose-BSA column was always <1%. These immunoabsorption studies demonstrate that both activities were due to a single hybridoma antibody.
The dual reactivities of the hybridoma autoantibodies were further proven by a series of competition experiments. The binding of RF activity to Fc fragments was analyzed after preincubation of the hybridoma antibody with HIgG and dDNA. Those antibodies that showed dual reactivity by direct binding and absorption experiments were competed by both HIgG and dDNA. A hybridoma antibody with only RF activity and lacking anti-DNA activity was competed by HIgG but not by dDNA. These competition experiments support the view that one autoantibody can have dual reactivities. The monoclonality ofthese antibodies was further substantiated by isoelectric focusing.
The hybridoma autoantibodies described in this study were found to react best with dDNA, of the nuclear antigens tested. Many of these were initially selected for DNA-binding activity, and so might be better described as anti-DNA antibodies with RF activity than as RF with DNA-binding activity. Similar findings, in which hybridoma autoantibodies selected for RF activity exhibited higher binding to dDNA and histones, have been reported by Rubin et al. (24) using monoclonal autoantibodies derived from MRL/lpr mice. The latter group of investigators have described heterohybridoma (human-mouse) antibodies from patients with RA and SLE that also react with HIgG, dDNA, and histones (25) . Preliminary observations using commercial histone preparations demonstrated that 3 ofour 17 RF/ anti-DNA hybridoma antibodies also bound to isolated histones (data not shown).
To date, the basis of the dual reactivity of these hybridoma antibodies with both HIgG and nuclear antigens cannot be explained by structural similarities between HIgG and the crossreacting antigens. Although this does not preclude the possibility that HIgG and nuclear antigens share structural epitopes, an alternative explanation may be that these cross-reactive antibodies represent polyfunctional antibodies. The concept of polyfunctional antibodies refers to the multispecificity of antibodies for different antigens that are structurally unrelated (26). In the case of the mouse myeloma protein 460, which binds the haptens E-DNP-lys and 2-methyl-1,4-naphthoquinone ( 
